TF and neoplasm: Indeed, procoagulant, PS-expressing tumor-derived EVs provide initiation sites for blood coagulation and tumor-derived EVs may activate platelets and promote their aggregation through both TF-dependent and TF-independent mechanisms [109,240,241,242].